Table 1.
Characteristics of HC-treated and matched control infants.
| HC-treated (n = 14) | Control (n = 14) | p | |
|---|---|---|---|
| Gestational age (weeks) | 24.8 ± 0.9 | 25.2 ± 0.9 | NS |
| Birthweight (g) | 706 ± 158 | 716 ± 156 | NS |
| Sex (male/female) | 9/5 | 9/5 | NS |
| Race/ethnicity (W/AA/His) | 6/4/4 | 7/5/1 | NS |
| Antenatal corticosteroid (no/yes) | 0/14 | 2/12 | NS |
| Average RSS (days 7–14) | 4.1 ± 1.3 | 3.8 ± 1.3 | NS |
| BPD36 weeks (no/yes) | 6/8 | 5/9 | NS |
| BPD40 weeks (no/yes) | 8/6 | 8/6 | NS |
| Late surfactant (no/yes) | 9/5 | 8/6 | NS |
| Age start HC (days) | 16.0 ± 6.6 | – | |
| Days with urine samples | 36 ± 11 | 34 ± 7 | NS |
| Age at full oral feeds (days) | 35.1 ± 6.1 | 23.3 ± 4.9 | 0.0001 |
Data are mean ± SD with p value by unpaired t-test or Fisher’s exact test. There are no differences in demographics or clinical parameters between groups except for later age at full oral feeds for HC-treated infants.
W white, AA African-American, His Hispanic.